Strategic alliance for clinical research announced

Article

Research Dynamics Consulting Group and ClinROC LLC have announced a strategic alliance to provide clinical research and product development services for the ophthalmic industry.

Research Dynamics Consulting Group and ClinROC LLC have announced a strategic alliance to provide clinical research and product development services for the ophthalmic industry.

ClinROC LLC will collaborate with Research Dynamics Consulting Group to offer clinical knowledge and experience in ophthalmology. The move will see cost-efficient conduct and management of clinical research trials for the ophthalmic, biologic and medical device industries.

Lorraine D. Ellis, CEO of the Research Consulting Group, commented, "Working with ClinROC provides our clients with our operational efficiency and ophthalmology trial experience together with ClinROC’s extensive medical and clinical expertise.” The strategic partnership with Research Dynamics Consulting Group is the latest exciting development for ClinROC, LLC and concentrates on meeting the development needs of ophthalmic medical devices, pharmaceuticals and diagnostics."

Dr Tara Vaz, Clinical Affairs and Co-Founder of ClinROC LLC, added, "This alliance allows our companies to conduct various designs and sizes of clinical trials to the highest quality standards, while providing the medical, clinical and scientific oversight to ensure the robustness of the outcomes."

Recent Videos
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
© 2024 MJH Life Sciences

All rights reserved.